Virtual Event, September 9, 2020
Thank you for attending the 2020 Technology Showcase on September 9th. The 4th annual event highlighted technologies being developed at the NCI and the Frederick National Laboratory for Cancer Research (FNL) to encourage technology licensing and collaborations, startup company formation and the translation of NCI discoveries into solutions to benefit patients. If you are interested in learning more about the featured technologies and would like for someone to follow-up with you, please contact us at ncitechtransfer@mail.nih.gov.
|
OVERVIEW:
|
|---|
Date and Time
Wednesday, September 9, 2020
11:45 AM - 5:30 PM, EST U.S.
LinkedIn Event:
Join our concurrent LinkedIn event to encourage engagement and networking
Agenda:
11:45 AM - WebEx event opens
Welcome & Keynote Presenters
Noon - 12:30 PM
Kelly Schulz, Secretary, Maryland Department of Commerce
Howard Bland, Sr. Director Supply Chain, Kite, a Gilead Company
Technology Session 1
12:30 - 1:25 PM
|
Moderator: Michael Salgaller, Ph.D., TTC, Invention Development and Marketing Unit Supervisor |
| Stephan Stern, Ph.D., DABT, Laboratory Co-Director, Director of Research and Development, Nanotechnology Characterization Laboratory - "Polymeric Delivery Platform for Therapeutics" E-097-2017 |
| Udo Rudloff, M.D., Ph.D., Investigator, NCI CCR Pediatric Oncology Branch - "Use and Preparation of CD206 Small Molecule Modulators as Therapeutics for CD206-Expressing Cancers" (E-105-2019) |
| Genoveffa Franchini, M.D., Senior Investigator, NCI CCR, Vaccine Branch - "Preventing HIV Using a Novel Recombinant gp120 Vaccine Modified with a V1-region Deletion" (E-160-2018) |
| Presented by: Herui Wang, Ph.D., NCI CCR, Neuro-Oncology Branch Inventor: Zhengping Zhuang, M.D., Ph.D., Senior Investigator, NCI CCR, Neuro-Oncology Branch - "Use of the TP5 Peptide for the Treatment of Cancer" (E-007-2019) |
| Javed Khan, M.D., Deputy Chief, NCI CCR, Genetics Branch - "Fibroblast Growth Factor Receptor 4 (FGFR4) Monoclonal Antibodies and Methods of Their Use" (E-264-2015) |
| *Order of presentations subject to change If you are interested in learning more about these technologies and would like for someone to follow-up with you, please contact us at ncitechtransfer@mail.nih.gov. |
Panel Session 1
1:30 - 2:25 PM
The following panels will be offered concurrently. Attendee selects one. Time is subject to change.
Panel 1: How to Attract Investors and Funding for Your Company(to attend this session, attendees stay connected to the primary WebEx Event link) |
|---|
|
Moderator: Elizabeth Cho-Fertikh, Ph.D. Co-Founder, MEDA Angels, Founder, ECF Biosolutions
|
Panel 2: Partnering with the NCI and FNL to Advance Innovation to Benefit your Pipeline and Your Bottom-line(to attend this session, attendees connected to a separate WebEx Event link |
|---|
|
Moderator: Vladimir Popov, Ph.D., Director, FNL Partnership Development Office
|
Technology Transfer Ambassadors Program (TTAP) Virtual Poster Sessions
2:30 - 3:25 PM
Posters prepared in partnership with NCI's TTAP will highlight technologies available for licensing and/or commercialization. The following Poster Sessions will be offered concurrently. Attendee selects one.
Poster Group 1
(to attend this session, attendees stayed connected to the primary WebEx Event link)
|
Moderator: Laura Prestia, Ph.D., TTC, Communications and Strategic Initiatives Manager, TTAP Program Lead |
| Presented by: Xiaoli Weng, Ph.D., TTC Fellow Inventor: Stavroula Mili, Ph.D. , NCI CCR, Laboratory of Cellular and Molecular Biology, "Antisense oligos that block cancer cell migration and invasion" (E-041-2020) VIEW ONE-MINUTE TECHNOLOGY PITCH |
| Presented by: Cindo Nicholson, Ph.D., TTAP Ambassador Inventor: Liyanage Perera Ph.D., NCI, CCR, Lymphoid Malignancies Branch, "Chimeric Antigen Receptor (CAR) that Targets Chemokine Receptor CCR4 and its Use in Treating Cancer" (E-258-2016) VIEW ONE-MINUTE TECHNOLOGY PITCH |
| Presented by: Mukta Nag, Ph.D., TTAP Senior Ambassador Inventor: Joel Schneider, Ph.D., NCI, CCR, Chemical Biology Laboratory, "Peptide Hydrogels for Rate-Controlled Delivery of Therapeutics" E-188-2017 VIEW ONE-MINUTE TECHNOLOGY PITCH |
| Presented by: Jonathan Motley, Ph.D., TTC Fellow Inventor: Mitchell Ho, Ph.D. NCI, CCR, Laboratory of Molecular Biology, "High Affinity Nanobodies Targeting B7-H3 (CD276) for Treating Multiple Solid Tumors" E-185-2019 VIEW ONE-MINUTE PITCH |
| Presented by: Weiwei Dai, Ph.D., *Johns Hopkins University Student Inventor: Stuart Le Grice, Ph.D., NCI, CCR, Basic Research Laboratory "(lncRNA) as Anticancer Agents" (E-060-2018) VIEW ONE-MINUTE PITCH |
| Presented by: Eric Ho, Ph.D., Transition to Industry (T2I) fellow and co-inventor Inventor: David FitzGerald, Ph.D. NCI, CCR, Laboratory of Molecular Biology "EGFRvIII Antibodies for the Treatment of Human Cancer" (E-103-2019) VIEW ONE-MINUTE PITCH |
| *Select posters were developed through the TTAP partnership with the Johns Hopkins University If you are interested in learning more about these technologies and would like for someone to follow-up with you, please contact us at ncitechtransfer@mail.nih.gov. |
Poster Group 2
(to attend this session, attendees connected to a separate WebEx Event)
|
Moderator: Abritee Dhal, Ph.D., TTC Technology Transfer Manager, TTAP Team Lead |
|---|
| Presented by: Albert Burgess-Hull, Ph.D., TTAP Ambassador Inventor: Melvin DePamphilis, Ph.D., Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH Distinguished Investigator, "Combined PIKFYVE and p38 MAP Kinase Inhibition for Treating Cancer" (E-138-2019) VIEW ONE-MINUTE PITCH |
| Presented by: Berna Uygur, Ph.D., TTC Fellow Inventor: Xin Wei Wang, Ph.D. NCI, CCR, Laboratory of Human Carcinogenesis, "A Viral Exposure Signature to Define and Detect Early Onset Hepatocellular Carcinoma" (E-174-2019) VIEW ONE-MINUTE PITCH |
| Presented by: Diptadip Dattaroy, Ph.D., TTAP Ambassador/TTC Fellow Inventor: Stephen Hewitt, M.D., Ph.D., NCI, CCR, Laboratory of Pathology, "Ratio Based Biomarkers for the Prediction of Cancer Survival" (E-025-2009) VIEW ONE-MINUTE PITCH |
| Presented by Fei Zhao, Ph.D., TTAP Ambassador Inventor: Allan Weissman, M.D. NCI, CCR, Laboratory of Protein Dynamics and Signaling, "Peptides that Modulate Endoplasmic Reticulum (ER)-Associated Degradation by Sequestering" (E-122-2018) VIEW ONE-MINUTE PITCH |
|
Presented by Hiba Alsaffar, Ph.D., TTC Fellow |
Technology Session 2
3:30 - 4:20 PM
|
Moderator: Maggie Scully, Ph.D., Senior Strategic Business Development Analyst, FNL Partnership Development Office |
|---|
| Brad St. Croix, Ph.D., Senior Associate Scientist, NCI CCR, Mouse Cancer Genetics Program - "Fully Human Antibodies and Antibody Drug Conjugates Targeting CD276 (B7-H3) for the Treatment of Cancer" (E-250-2014) |
| Stavroula Mili, Ph.D., NCI CCR, Laboratory of Cellular and Molecular Biology - "Antisense Oligonucleotides against Cancer Cell Migration and Invasion" (E-041-2020) |
| Uma Mudunuri M.S., Advanced Biomedical Computational Science, FNL – "Analytics and Visualization through interactive Data (AViD) Dashboards" |
| Benjamin Madej, Ph.D., Data Scientist, Accelerating Therapeutics for Opportunities in Medicine (ATOM), FNL – “AMPL: A Data-Driven Modeling Pipeline for Drug Discovery” |
| *Order of presentations subject to change If you are interested in learning more about these technologies and would like for someone to follow-up with you, please contact us at ncitechtransfer@mail.nih.gov. |
Panel Session 2:
4:25 – 5:15 PM
The following panels will be offered concurrently. Attendee selects one.
Panel 3: Government and Non-Profit Funding and Resources for Startups(to attend this session, attendees stayed connected to the primary WebEx Event link) |
|---|
|
Moderator: Heather Gramm, CEcD, Senior Director, Strategic Industries and Entrepreneurship, Maryland Department of Commerce
|
Panel 4: Leveraging Incubators and Accelerators to Speed Tech Licensing and Commercialization(to attend this session, attendees connected to a separate WebEx event. |
|---|
|
Moderator: Kathie Callahan Brady, CEO, Frederick Innovative Technology Center Inc. (FITCI)
|